LPCN
Price
$4.38
Change
-$0.22 (-4.78%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
23.48M
SPRY
Price
$13.55
Change
+$0.07 (+0.52%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
1.32B
56 days until earnings call
Ad is loading...

LPCN vs SPRY

Header iconLPCN vs SPRY Comparison
Open Charts LPCN vs SPRYBanner chart's image
Lipocine
Price$4.38
Change-$0.22 (-4.78%)
Volume$100
Capitalization23.48M
ARS Pharmaceuticals
Price$13.55
Change+$0.07 (+0.52%)
Volume$20.24K
Capitalization1.32B
LPCN vs SPRY Comparison Chart
Loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPCN vs. SPRY commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a Hold and SPRY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (LPCN: $4.39 vs. SPRY: $13.55)
Brand notoriety: LPCN and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 95% vs. SPRY: 90%
Market capitalization -- LPCN: $23.48M vs. SPRY: $1.32B
LPCN [@Biotechnology] is valued at $23.48M. SPRY’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, LPCN is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 3 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • LPCN’s TA Score: 3 bullish, 2 bearish.
  • SPRY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both LPCN and SPRY are a good buy in the short-term.

Price Growth

LPCN (@Biotechnology) experienced а -4.98% price change this week, while SPRY (@Biotechnology) price change was +12.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

LPCN is expected to report earnings on Aug 09, 2023.

SPRY is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.32B) has a higher market cap than LPCN($23.5M). SPRY YTD gains are higher at: 28.436 vs. LPCN (-10.041). LPCN has higher annual earnings (EBITDA): -3.68M vs. SPRY (-60.51M). SPRY has more cash in the bank: 205M vs. LPCN (19.8M). SPRY has less debt than LPCN: SPRY (102K) vs LPCN (1.48M). LPCN has higher revenues than SPRY: LPCN (7.92M) vs SPRY (2.57M).
LPCNSPRYLPCN / SPRY
Capitalization23.5M1.32B2%
EBITDA-3.68M-60.51M6%
Gain YTD-10.04128.436-35%
P/E RatioN/AN/A-
Revenue7.92M2.57M309%
Total Cash19.8M205M10%
Total Debt1.48M102K1,453%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPCNSPRY
RSI
ODDS (%)
N/A
Bullish Trend 16 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 16 days ago
83%
Bearish Trend 16 days ago
85%
Momentum
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 16 days ago
83%
MACD
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 16 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
84%
Bullish Trend 16 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 16 days ago
83%
Bearish Trend 16 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 24 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 16 days ago
82%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
View a ticker or compare two or three
Ad is loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTKG1.030.04
+4.25%
X3 Holdings Co Ltd
VKTX34.051.18
+3.59%
Viking Therapeutics
RMCF1.920.02
+1.05%
Rocky Mountain Chocolate Factory
SASR33.88-0.36
-1.05%
Sandy Spring Bancorp
PINS31.64-0.43
-1.34%
Pinterest

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
-4.57%
SPRY - LPCN
63%
Loosely correlated
+0.52%
IPA - LPCN
43%
Loosely correlated
+30.73%
ZNTL - LPCN
38%
Loosely correlated
+0.44%
TARA - LPCN
30%
Poorly correlated
-1.47%
CRSP - LPCN
27%
Poorly correlated
+6.48%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+0.52%
LPCN - SPRY
63%
Loosely correlated
-4.57%
STRO - SPRY
39%
Loosely correlated
-1.01%
SLNO - SPRY
39%
Loosely correlated
-1.50%
TSVT - SPRY
37%
Loosely correlated
+2.86%
KRYS - SPRY
36%
Loosely correlated
+1.26%
More